Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure

Background Increased cardiac G protein-coupled receptor kinase-2 (GRK2) expression has a pivotal role at inducing heart failure (HF)-related β-adrenergic receptor (βAR) dysfunction. Importantly, abnormalities of βAR signalling in the failing heart, including GRK2 overexpression, are mirrored in circulating lymphocytes and correlate with HF severity. Exercise training has been shown to exert several beneficial effects on the failing heart, including normalization of cardiac βAR function and GRK2 protein levels. In the present study, we evaluated whether lymphocyte GRK2 levels and short-term changes of this kinase after an exercise training programme can predict long-term survival in HF patients. Methods For this purpose, we prospectively studied 193 HF patients who underwent a 3-month exercise training programme. Lymphocyte GRK2 protein levels, plasma N-terminal pro-brain natriuretic peptide, and norepinephrine were measured at baseline and after training along with clinical and functional parameters (left ventricular ejection fraction, NYHA class, and peak-VO2). Cardiac-related mortality was evaluated during a mean follow-up period of 37 ± 20 months. Results Exercise was associated with a significant reduction of lymphocyte GRK2 protein levels (from 1.29 ± 0.52 to 1.16 ± 0.65 densitometric units, p < 0.0001). Importantly, exercise related changes of GRK2 (delta values) robustly predicted survival in our study population. Interestingly, HF patients who did not show reduced lymphocyte GRK2 protein levels after training presented the poorest outcome. Conclusions Our data offer the first demonstration that changes of lymphocyte GRK2 after exercise training can strongly predict outcome in advanced HF.

[1]  D. Leosco,et al.  Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis , 2013, PloS one.

[2]  P. Filardi,et al.  β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? , 2013, Journal of Alzheimer's disease : JAD.

[3]  P. Gargiulo,et al.  Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure , 2012, British journal of pharmacology.

[4]  D. Leosco,et al.  Myocardial β2‐adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure , 2012, British journal of pharmacology.

[5]  H. Middlekauff,et al.  Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age , 2012, European journal of preventive cardiology.

[6]  D. Leosco,et al.  Targeting the &bgr;-Adrenergic Receptor System Through G-Protein–Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure From Bench to Bedside , 2012, Circulation. Heart failure.

[7]  M. van Brussel,et al.  Effect of outpatient exercise training programmes in patients with chronic heart failure: a systematic review , 2012, European journal of preventive cardiology.

[8]  T. Trikalinos,et al.  Drug and Device Effects on Peak Oxygen Consumption, 6-Minute Walk Distance, and Natriuretic Peptides as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction , 2011, Circulation. Heart failure.

[9]  D. Leosco,et al.  GRK2 as a novel gene therapy target in heart failure. , 2011, Journal of molecular and cellular cardiology.

[10]  D. Leosco,et al.  Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. , 2010, American journal of physiology. Heart and circulatory physiology.

[11]  D. Leosco,et al.  The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. , 2009, Cardiovascular research.

[12]  W. Kraus,et al.  Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[13]  W. Koch,et al.  Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure , 2009, Circulation.

[14]  S. Houser,et al.  G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure , 2008, Circulation research.

[15]  F. Rengo,et al.  Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. , 2008, Cardiovascular research.

[16]  F. Rengo,et al.  Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation. , 2007, American journal of physiology. Heart and circulatory physiology.

[17]  M. Schalij,et al.  Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure. , 2007, Journal of cardiac failure.

[18]  D. Leosco,et al.  Exercise training affects age-induced changes in SOD and heat shock protein expression in rat heart , 2006, Experimental Gerontology.

[19]  F. Giallauria,et al.  Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[20]  F. Giallauria,et al.  Long-term effects of cardiac rehabilitation on end-exercise heart rate recovery after myocardial infarction , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[21]  W. Koch,et al.  Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. , 2006, Journal of cardiac failure.

[22]  D. Leosco,et al.  Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. , 2005, European heart journal.

[23]  S. Houser,et al.  Improved Myocardial &bgr;-Adrenergic Responsiveness and Signaling With Exercise Training in Hypertension , 2005, Circulation.

[24]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[25]  M. Piepoli,et al.  Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.

[26]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[27]  J. Port,et al.  Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes , 2004, The clinical investigator.

[28]  P. Abete,et al.  Exercise restores β-adrenergic vasorelaxation in aged rat carotid arteries , 2003 .

[29]  P. Abete,et al.  Exercise restores beta-adrenergic vasorelaxation in aged rat carotid arteries. , 2003, American journal of physiology. Heart and circulatory physiology.

[30]  J. Cohn The Sympathetic Nervous System in Heart Failure , 2002, Circulation.

[31]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[32]  Salim Yusuf,et al.  Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). , 2002, American heart journal.

[33]  N. Dzimiri,et al.  Characterization Of Lymphocyte β2‐Adrenoceptor Signalling In Patients With Left Ventricular Volume Overload Disease , 2002, Clinical and experimental pharmacology & physiology.

[34]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[35]  K. Werdan,et al.  Impaired β-adrenergic control of immune function in patients with chronic heart failure: reversal by β1-blocker treatment , 2001, Basic Research in Cardiology.

[36]  K. Werdan,et al.  Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta1-blocker treatment. , 2001, Basic research in cardiology.

[37]  G. Schuler,et al.  Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. , 2000, JAMA.

[38]  R. Lefkowitz,et al.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.

[39]  R. Lefkowitz,et al.  G protein-coupled receptor kinases. , 1998, Annual review of biochemistry.

[40]  N. Dzimiri,et al.  RELATIONSHIP BETWEEN ALTERATIONS IN LYMPHOCYTE AND MYOCARDIAL β‐ADRENOCEPTOR DENSITY IN PATIENTS WITH LEFT HEART VALVULAR DISEASE , 1996, Clinical and experimental pharmacology & physiology.

[41]  M. Böhm,et al.  Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. , 1994, Circulation research.

[42]  R. Lefkowitz G protein—coupled receptor kinases , 1993, Cell.

[43]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[44]  O. Brodde,et al.  Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. , 1986, Science.